top of page

An Interview With Scott Horton: Bill Hicks, The War On Drugs & Scott's Anti War Journey

In this interview with Scott Horton, we talk about Bill Hicks, the war on drugs, world government, Joe Biden, Iraq and Scott's journey to his current path. As Scott's main focus is usually foreign policy, I thought it would be great to get his thoughts on some other topics. Unsurprisingly, foreign policy still came up in certain segments, nevertheless, the majority of the interview was not focused on foreign policy. I hope you enjoyed the interview.


Bio


Scott Horton is director of the Libertarian Institute, editorial director of Antiwar.com, host of Antiwar Radio on Pacifica, 90.7 FM KPFK in Los Angeles, California and podcasts the Scott Horton Show from ScottHorton.org. He’s the author of the 2021 book Enough Already: Time to End the War on Terrorism, the 2017 book, Fool’s Errand:Time to End the War in Afghanistan and editor of the 2019 book The Great Ron Paul: The Scott Horton Show Interviews 2004–2019 and the 2022 book Hotter Than the Sun: Time to Abolish Nuclear Weapons. Horton is currently at work on the forthcoming book Provoked: How America Started the New Cold War With Russia and the Catastrophe in Ukraine. He’s conducted more than 5,900 interviews since 2003.




Please feel free to comment if I have missed any links in the show notes.




https://rumble.com/user/TruthOverComfort



Tik Tok @truthovercomfort https://www.tiktok.com/@truthovercomfort


Twitter @truthovercomfo2 - https://twitter.com/truthovercomfo2


Instagram truthovercomfort30 - https://www.instagram.com/truthovercomfort30/


Scott Horton's Links





Books



Show Notes



























"Attention Deficit Disorder with Hyperactivity (ADHD): DESOXYN tablets are indicated as an integral part of a total treatment program which typically includes other remedial measures (psychological, educational, social) for a stabilizing effect in children over 6 years of age with a behavioral syndrome characterized by the following group of developmentally inappropriate symptoms: moderate to severe distractibility, short attention span, hyperactivity, emotional lability, and impulsivity. " FDA
















bottom of page